Drug Profile
Influenza A virus vaccine H7N1 - Sanofi/FLUPAN
Latest Information Update: 04 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Class Influenza A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H7N1 subtype
Most Recent Events
- 23 Jun 2007 sanofi-pasteur completes a phase I trial in Influenza-A virus H7N1 subtype in Norway
- 19 Sep 2006 Phase-I clinical trials in Influenza-A virus H7N1 subtype in Norway (Parenteral)